MedPlus raises ₹418 crores from Anchor Investors ahead of IPO
Written by Lucky Wilson | KGTO Writer on December 11, 2021
One of the largest pharmacy retailer MedPlus raised ₹418 crores from anchor investors on December 10, 2021 Friday before the IPO. The MedPlus IPO is to open on December 13, Monday. The company allotted a total of 52,51,111 equity shares to 36 Anchor investors at an upper price band of ₹796. The anchor investors list includes 7 Mutual Funds through a total of 18 schemes. The company is going to raise ₹1398 crores. Check out the final list of MedPlus Anchor Investors given below:
MedPlus Anchor Investors List:
The IPO Committee of the Board of Directors of the Company and the Investor Selling Shareholder vide resolution on December 10, 2021, in consultation with Axis Capital Limited, Credit Suisse Securities (India) Private Limited, Edelweiss Financial Services Limited and Nomura Financial Advisory and Securities (India) Private Limited (the “Book Running Lead Managers” or “BRLMs”), have finalized allocation of 52,51,111 Equity Shares in aggregate, to Anchor Investors at the Anchor Investor Allocation Price of ₹796/- per Equity Share (including share premium of ₹794/- per Equity Share). The details are given below:
 |
The MedPlus IPO to open on 13 December and closes on 25 December 2021. The price band is fixed at ₹780 to ₹796. MedPlus IPO application minimum bid is for 18 Shares (₹14,328) and maximum bid is 234 shares (₹186,264). The Book Running Lead Managers of the IPO are Axis Capital Limited, Credit Suisse Securities (India) Private Limited, Edelweiss Financial Services Limited, Nomura Financial Advisory and Securities (India) Private Limited.
To know more about latest IPO gmp please visit correctsuccess.com
